<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN"
       "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" dtd-version="1.3" article-type="brief-report" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="nlm-ta">Ulutas Med J</journal-id>
   <journal-title-group>
    <journal-title>The Ulutas Medical Journal</journal-title>
    <abbrev-journal-title>Ulutas Med J</abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="ppub">2149-0430</issn>
   <issn pub-type="epub">2149-388X</issn>
   <publisher>
    <publisher-name>Hayriye Zehra Ulutaş</publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">10.5455/umj.20200812015436</article-id>
   <article-id pub-id-type="publisher-id">124761</article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>Short Communication</subject>
    </subj-group>
    <subj-group subj-group-type="subject">
     <subject>Microbiology</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title>COVID-19: Maternal and Child Health Care</article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" corresp="yes">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3785-5670</contrib-id>
     <name name-style="western">
      <surname>Zafar</surname>
      <given-names>Humaira Zafar</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff1">1</xref>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3785-5670</contrib-id>
     <name name-style="western">
      <surname>Mirza</surname>
      <given-names>Irfan Ali</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff2">2</xref>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3785-5670</contrib-id>
     <name name-style="western">
      <surname>Hussain</surname>
      <given-names>Wajid Hussain</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff3">3</xref>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8913-4560</contrib-id>
     <name name-style="western">
      <surname>Iqbal</surname>
      <given-names>Khadija</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff4">4</xref>
    </contrib>
    <aff id="aff1">
     <label>1</label>
     <institution-wrap>
      <institution>Pathology, Consultant Microbiologist, Al Nafees Medical College &amp; Hospital, Islamabad, Pakistan</institution>
     </institution-wrap>
    </aff>
    <aff id="aff2">
     <label>2</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/04se3fj97</institution-id>
      <institution>Pathology, Consultant Microbiologist, Armed Forces Institute of Pathology, Rawalpindi, Pakistan</institution>
     </institution-wrap>
    </aff>
    <aff id="aff3">
     <label>3</label>
     <institution-wrap>
      <institution>Anatomy, Al Nafees Medical College &amp; Hospital, Islamabad, Pakistan n</institution>
     </institution-wrap>
    </aff>
    <aff id="aff4">
     <label>4</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/0039pbm21</institution-id>
      <institution>Al Nafees Medical College and Hospital, Anatomical Society, College of Physicians and Surgeons, Pakistan</institution>
     </institution-wrap>
    </aff>
   </contrib-group>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2020-09-19">
    <day>19</day>
    <month>09</month>
    <year>2020</year>
   </pub-date>
   <pub-date publication-format="print" date-type="collection">
    <year>2020</year>
   </pub-date>
   <volume>6</volume>
   <issue>3</issue>
   <fpage>180</fpage>
   <lpage>184</lpage>
   <history>
    <date date-type="received" iso-8601-date="2020-08-13">
     <day>13</day>
     <month>08</month>
     <year>2020</year>
    </date>
    <date date-type="rev-recd" iso-8601-date="2020-08-20">
     <day>20</day>
     <month>08</month>
     <year>2020</year>
    </date>
    <date date-type="accepted" iso-8601-date="2020-08-30">
     <day>30</day>
     <month>08</month>
     <year>2020</year>
    </date>
   </history>
   <permissions>
    <copyright-statement>© 2020 The Author(s)</copyright-statement>
    <copyright-year>2020</copyright-year>
    <license>
     <ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
     <license-p>This is an open access article distributed under the CC BY-NC 4.0 licence.</license-p>
    </license>
   </permissions>
   <self-uri xlink:href="https://www.ulutasmedicaljournal.com/?mno=124761"/>
   <self-uri content-type="pdf" xlink:href="https://www.ulutasmedicaljournal.com/pdf/124761.pdf"/>
   <abstract>
    <p>In the sunset of 2019, the world encountered the beginning of a pandemic due to corona viral infection disease (COVID-19). The rapid spread via respiratory route transmission, absence of vaccine and specific anti virals is the main reason for making the situation worse. Like every aspect COVID-19 was found to be of great concerns in maternal and child health care. The objective of this short communication was to found the effects of COVID-19 in maternal and child health care. It was identified that the clinical manifestations of COVID in pregnant and non-pregnant patients have same manifestations. The mode of delivery even has no significant association with specific infection. The evidence to support inutero peripartum or postpartum transmission is also deficient. Only positive finding observed was the presence of fetal distress. So it was clinched that after birth neonates must be kept in isolation for careful evaluation of any sign of infection and hence it's management. It was concluded that serial follow up investigations like cardiactocography, Doppler's and amniocentesis should be done to assess fetal wellbeing in the intrauterine period. However, in post partum period both mother and baby should remain in isolation for careful monitoring of any signs of infection and hence timely management.</p>
   </abstract>
   <kwd-group kwd-group-type="author">
    <kwd>COVID-19</kwd>
    <kwd>Pregnancy</kwd>
    <kwd>Maternal outcome</kwd>
    <kwd>Neonatal Outcome</kwd>
    <kwd>Diagnostic modalities</kwd>
   </kwd-group>
   <funding-group>
    <funding-statement>Funding information was not reported in the published version of this article.</funding-statement>
   </funding-group>
  </article-meta>
 </front>
 <body>
  <sec id="sec-1">
   <title>Introduction</title>
   <p id="b-1">Severe Acute Respiratory Syndrome - Corona Viral Infection (SARS-CoV-II) Virus outbreaks have been occurring in the world for many decades. In December 2019, Severe Acute Respiratory Syndrome Corona viral infection (SARS-CoV-II) epidemic started from Wuhan China. Afterwards it encompassed two dozen countries with death toll to around millions across Globe. In 2020 the disease caused by this new SARS-CoV-II, had taken a shape of a pandemic, which is rapidly spreading and taking many lives daily. Few years back the member of same corona vial group i.e Middle east respiratory syndromeCorona viral infection (MERS-CoV) began in Saudi Arabia and took thousands of lives. Until that time till to date, the scientist are working to discover the vaccines and anti virals for CoV, but satisfactory results are deficient (    <xref ref-type="bibr" rid="ref1">1</xref>
).</p>
   <sec id="sec-2">
    <title>Routes of Transmission</title>
    <p id="b-2">In the absence of vaccines and anti virals, the respiratory mode of spread is adding up to the worsening of situation. The first case of the CoVID-19 disease was through direct exposure to the Huanan seafood wholesale market of Wuhan, the animal-to-human transmission was thought to be the cause. The new virus seemed to be highly contagious, harboring a property for transmission amongst humans. The people who have symptoms are the most frequent source of COVID-19 spread (     <xref ref-type="bibr" rid="ref2">2</xref>
). However, in subclinical or asymptomatic period of 3-4 days (5.2 days approx.) is even more dangerous. Unknowingly person can be a source for infection transmission. But still a debate is there for infection transmission in asymptomatic phase (     <xref ref-type="bibr" rid="ref3">3</xref>
,     <xref ref-type="bibr" rid="ref4">4</xref>
). The Global statistical in current pandemic scenario, concluded that each positive patient can transmit the infection to an additional 2.2 individuals. This is how the regional epidemic doubles every seven days. Cumulative score of various regions around the Globe thus, doubles every week (     <xref ref-type="bibr" rid="ref2">2</xref>
).</p>
   </sec>
   <sec id="sec-3">
    <title>Predisposition &amp; Clinical Presentations</title>
    <p id="b-3">The published data strongly supports that immunosuppressed, elderly, or patients with comorbidities are at high risk for acquiring infection. The most common symptoms in incubation period includes fever which is non responsive to antipyretics, and a state of malaise. Later on there is development of dry cough in the acute phase. After 5-7 days, high risk patients, begin to experience shortness of breath and increased respiratory rate. However, in more fragile elderly patients, dyspnea may already appear at the onset of symptoms (     <xref ref-type="bibr" rid="ref5">5</xref>
). The frequency estimation of clinical presentations revealed that the highest percentage was seen for fever in 87.9%. This with passage of time was followed by dry cough (67.7%), fatigue(38.1%), and sputum production (33.4%). With deterioration of infection, next in sequence were shortness of breath (18.6%), myalgia/arthralgia (14.8%), headache (13.6%) sore throat (13.9%), and chills (11.4%). Less common symptoms were congestion (0.8%), nasal congestion (4.8%), nausea/vomiting (5%), diarrhea (3.7%), and hemoptysis (0.9%)(     <xref ref-type="bibr" rid="ref6">6</xref>
).</p>
   </sec>
   <sec id="sec-4">
    <title>Preventive Measure</title>
    <p id="b-4">Published data suggests that the use of isolation is the best way to contain this epidemic and pandemic. Close contact with patients spreads the infection at a faster rate. While practicing good hygienicmeasures like frequent hand washing, maintaining cleanliness are the keys to combat the spread of this infection. Besides this, for hospital settings, wearing of personal protective equipments(PPEs), frequent use of hand sanitizers, use of surface good disinfectants, can help reducing the spread of infection (     <xref ref-type="bibr" rid="ref2">2</xref>
,     <xref ref-type="bibr" rid="ref5">5</xref>
).</p>
    <p id="b-5">In the current scenario of COVID-19 pandemic, a rapidly spreading pattern was observed across the Globe. In the absence of vaccine and specific anti viral, we are left with only adoption ofpreventive measures to combat this infection. Besides ones preventive measures mentioned above, positive pregnant females must be dealt as high risk pregnancies (     <xref ref-type="bibr" rid="ref7">7</xref>
,     <xref ref-type="bibr" rid="ref8">8</xref>
).</p>
   </sec>
   <sec id="sec-5">
    <title>COVID-19 &amp; Pregnancy</title>
    <p id="b-6">Recklessly of the COVID-19, the presence of pneumonia in pregnancy exhibit high morbidity and mortality rates. It is considered one of the serious non-obstetric infection (     <xref ref-type="bibr" rid="ref9">9</xref>
). About 25% of such cases requires mechanical ventilation and intensive care treatment. In comparison with bacterial pneumonia, viral pneumonia is concomitant with higher morbidity and mortality rates. From such infection, common complications can be premature rupture of the membranes (PROM), intrauterine growth restriction(IUGR), intrauterine fetal death (IUFD), preterm labor, and neonatal death (     <xref ref-type="bibr" rid="ref6">6</xref>
).</p>
   </sec>
   <sec id="sec-6">
    <title>Maternal Outcomes Following COVID-19</title>
    <p id="b-7">Upon comparison with SARS-CoV-II (COVID- 19) and MERS-CoV, low mortality rate, and less severe maternal and fetal outcomes were seen in COVID-19, pregnant ladies. So far Global statistics revealed only 32 (n) positive cases of COVID-19 in pregnant ladies. Amongst those 32 cases, none was in first trimester of pregnancy. The mortality rate amongst all these were zero. In maximum cases (n=27), mode of delivery was caesarean section, while remaining five cases had normal vaginal delivery. The marked symptoms of fetal distress was the main reason for specific mode of pre term delivery (     <xref ref-type="bibr" rid="ref10">10</xref>
). In a published report by Zhu      <italic>et al</italic>
, it was concluded that only three women became symptomatic in the post-partum period. All after intensive care management completely recovered (     <xref ref-type="bibr" rid="ref11">11</xref>
).</p>
    <p id="b-8">One more study revealed the presence of identical symptoms via comparative analysis of COVID-19 in pregnant and non-pregnant females. In both groups the predisposing factors were same and were labelled as high risk groups. Presence of typical infiltrates in lungs suggestive of severe pneumonia were confirmed by computed tomography. While supportive lab studies showed decreased total leucocyte counts, lymphopenia, mild thrombo cytopenia and deranged liver function tests (     <xref ref-type="bibr" rid="ref6">6</xref>
).</p>
   </sec>
   <sec id="sec-7">
    <title>Transmission from Mother to Child</title>
    <p id="b-9">The good supportive evidence is deficient for to support the vertical transmission route of COVID-19. A published study in Lancet, describes the transmission routes for SARS- CoV-II. Various samples were collected i.e amniotic fluid, umbilical cord blood and throat swabs of the neonates instantly after delivery. Besides that milk samples were also taken in postpartum period. All the samples revealed negative results (     <xref ref-type="bibr" rid="ref10">10</xref>
). Moreover, placentas of positive cases were also examined. The histo pathologicalevaluation was negative to support the presence of infection. Concluding the published statistics, there is no evidence of intrauterine transmission of SARS-COV-2 onto the fetus (     <xref ref-type="bibr" rid="ref12">12</xref>
).</p>
   </sec>
   <sec id="sec-8">
    <title>Neonatal Outcomes</title>
    <p id="b-10">Nevertheless, cautiousness is obligatory to save the lives of babies born to a mother having COVID. This is direly required because the evidence for transmission inutero or peripartum phase is extremely deficient. The neonatologists recommended keeping those babies in isolation and to have their close monitoring, so that any sign of infection can be timely diagnosed. It was observed that the Apgar score after one and five minutes was found unremarkable in babies of positive mothers. The elevated cardiac enzymes were seen in one baby, on first post partum day which later proved to be non significant for clinical relevance (     <xref ref-type="bibr" rid="ref10">10</xref>
).</p>
    <p id="b-11">Amongst neonatal outcome, so far only one neonate turned to be positive, there was only one case of still birth and one mortality. Multi-organ failure along with disseminated intravascular coagulopathy on ninth day of life became the reason for mortality. While few neonates developed respiratory distress syndrome. Which was followed by gastro intestinal symptoms, fever, tachycardia and vomiting (     <xref ref-type="bibr" rid="ref13">13</xref>
).</p>
    <p id="b-12">Breastfeeding in Cases of Suspected Infection or Confirmed SARS-Cov-2 Infection In literature review regarding transmission of infection via breast feeding is deficient either for suspected or confirmed cases. But, still to be on safer side European institute of breast feeding and lactation recommends that the milk should be pumped off and feeding should be provided by healthy assistant (     <xref ref-type="bibr" rid="ref14">14</xref>
,     <xref ref-type="bibr" rid="ref15">15</xref>
).</p>
    <p id="b-13">Maternal &amp; Neonatal Samples for COVID-19 Diagnosis by RT-PCR To ensure maternal and child health, preferred samples can be umbilical cord blood, amniotic fluid, neonatal gastric samples, neonatal throat swab and breast milk samples. However, so far, there is no evidence supporting the vertical transmission of COVID-19 (     <xref ref-type="bibr" rid="ref10">10</xref>
).</p>
    <p id="b-14">Management of Infected Pregnant Patients &amp; Monitoring of Fetal Well Being The right of treatment and management of pregnants is equal to that of non-pregnant patient, provided clear contraindications there. Though the evidence for using remdesivir and hydroxychloroquine in pregnancy is yet deficient. But the benefit and potential risks should carefully be weighed and explained to the mother, for opting the management. This is the same decision as in case for opting any management in pregnancy. However, isolation and quarantine should be the first modality to go for, just like in any positive or suspected case. Mechanic ventilation and oxygen support should be arranged to manage for the signs of respiratory failure. Superimposed bacterial and other co infections should be managed along with specific COVID. Prior the start of empirical antibiotics, recommended protocols for blood cultures should be followed for accurate management. Moreover, all recommendations and guidelines for the adoption of specific mode of delivery are deficient (     <xref ref-type="bibr" rid="ref16">16</xref>
,     <xref ref-type="bibr" rid="ref17">17</xref>
).</p>
    <p id="b-15">In concerns for fetal monitoring, regular cardiotocography (CTG), Doppler and amniotic fluid analyses should be done to eliminate placental failure and hence the development of intrauterine growth retardation (IUGR) (     <xref ref-type="bibr" rid="ref17">17</xref>
).</p>
   </sec>
  </sec>
  <sec id="sec-9">
   <title>Conclusion</title>
   <p id="b-16">It was concluded that serial follow up investigations like cardiactocography, Doppler’s and amniocentesis should be done to assess fetal wellbeing in intrauterine period. However, in post partum period both mother and baby should remain in isolation for careful monitoring of any signs of infection and hence timely management.</p>
  </sec>
  <sec id="sec-10">
   <title>Recommendations</title>
   <p id="b-17">1. Serial sampling of mother and baby during the pregnancy and after birth are necessary for safe maternal &amp; child health care.</p>
   <p id="b-18">2.The preferred samples can be umbilical cord blood, neonatal throat swab, amniotic fluid, neonatal gastric and breast milk samples. 3.For the monitoring of fetal well-being, amniotic fluid analyses, Doppler and regular cardiotocography (CTG) should be done to eliminate placental failure and hence the development of IUGR.</p>
   <p id="b-19">4.The presence of fetal distress should be monitored carefully and can become an indication of cesarean section.</p>
   <p id="b-20">5.Neonatal isolation protocols should be strictly followed along with monitoring for the signs of infection, and blood complete picture. 6.European institute of breast feeding and lactation recommends that for positive or suspected cases, breast milk should be pumped off and feeding should be provided by healthy assistant.</p>
  </sec>
 </body>
 <back>
  <ref-list>
   <title>References</title>
   <ref id="ref1">
    <label>1</label>
    <mixed-citation publication-type="journal">Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020; 92(4):418-423</mixed-citation>
   </ref>
   <ref id="ref2">
    <label>2</label>
    <mixed-citation publication-type="journal">Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019- nCoV). Euro Surveill. 2020;25(4):20-58</mixed-citation>
   </ref>
   <ref id="ref3">
    <label>3</label>
    <mixed-citation publication-type="journal">Li Q, Guan X, Wu P. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med 2020;382:1199-1207</mixed-citation>
   </ref>
   <ref id="ref4">
    <label>4</label>
    <mixed-citation publication-type="journal">Rothe C, Schunk M, Sothmann P. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020;382:970-971</mixed-citation>
   </ref>
   <ref id="ref5">
    <label>5</label>
    <mixed-citation publication-type="journal">Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, etal. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221-</mixed-citation>
   </ref>
   <ref id="ref6">
    <label>6</label>
    <mixed-citation publication-type="journal">Stumpfe FM, Titzmann A, Schneider MO, Stelzl P, Kehl S, Fasching PA, etal. SARS-CoV-2 Infection in Pregnancy - a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome. Geburtshilfe Frauenheilkd. 2020;80(4):380-390</mixed-citation>
   </ref>
   <ref id="ref7">
    <label>7</label>
    <mixed-citation publication-type="journal">Zhang N, Jiang S, Du L. Current advancements and potential strategies in the development of MERS-CoV vaccines. Expert Rev Vaccines. 2014;13(6):761–774</mixed-citation>
   </ref>
   <ref id="ref8">
    <label>8</label>
    <mixed-citation publication-type="journal">Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia. Mil Med Res. 2020;7(1):4</mixed-citation>
   </ref>
   <ref id="ref9">
    <label>9</label>
    <mixed-citation publication-type="journal">Alfaraj SH, Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases &amp; review of the literature. J Microbiol Immunol Infect 2019;52(3):501-503</mixed-citation>
   </ref>
   <ref id="ref10">
    <label>10</label>
    <mixed-citation publication-type="journal">Mullins E, Evans D, Viner RM, Brien OP, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol. 2020;55(5):586-592</mixed-citation>
   </ref>
   <ref id="ref11">
    <label>11</label>
    <mixed-citation publication-type="journal">Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, etal. Clinical analysis of 10 neonates born to mothers with 2019‐ nCoV pneumonia. Transl Pediatr. 2020;9(1):51-60</mixed-citation>
   </ref>
   <ref id="ref12">
    <label>12</label>
    <mixed-citation publication-type="journal">Ng WF, Wong SF, Lam A. The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluation. Pathology. 2006;38(3):210-218</mixed-citation>
   </ref>
   <ref id="ref13">
    <label>13</label>
    <mixed-citation publication-type="journal">Zhu H, Wang L, Fang C. et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020;9(1):51-60</mixed-citation>
   </ref>
   <ref id="ref14">
    <label>14</label>
    <mixed-citation publication-type="journal">Coronavirus/COVID-19 und Stillen: Aktuelle Empfehlun gen. Website:[http://www.stillen -institut.com/de/coronavirus-co vid-19-und-stillen-aktuelle-empfehlungen. html?fbclid=IwAR3F8_iFQDAmyHxhGHtGlXPLy8VPGKFW9Dl OsFKH2cTqE2ci6_rEN7yed3c] Retrieved on 9, 2020</mixed-citation>
   </ref>
   <ref id="ref15">
    <label>15</label>
    <mixed-citation publication-type="journal">Coronavirus (SARS-CoV-2) Website:[ https://www.dggg. de/ news/hinweise-und-faq-zum-coronavirus-fuer-schwangere-und-saeuglinge-1181/] Retrieved on 19, 2020</mixed-citation>
   </ref>
   <ref id="ref16">
    <label>16</label>
    <mixed-citation publication-type="journal">Liang H, Acharya G. Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?. Acta Obstet Gynecol Scand. 2020;99(4):439-442</mixed-citation>
   </ref>
   <ref id="ref17">
    <label>17</label>
    <mixed-citation publication-type="journal">Rasmussen SA, Smulian JC, Lednicky JA.. Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know. Am J Obstet Gynecol 2020;222(5):415-426</mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>
